Low-dose spironolactone reduces plasma fibulin-1 levels in patients with type 2 diabetes and resistant hypertension
C S Oxlund, C Cangemi, J E Henriksen, I A Jacobsen, J Gram, K Schousboe, L Tarnow, W S Argraves, L M Rasmussen
13Citationer
(Scopus)
Fingeraftryk
Dyk ned i forskningsemnerne om 'Low-dose spironolactone reduces plasma fibulin-1 levels in patients with type 2 diabetes and resistant hypertension'. Sammen danner de et unikt fingeraftryk.